Business Courier: UC startup gets investment to advance trials
Sense Neuro Diagnostics’ technology can detect, monitor damage to the brain
A startup founded by four University of Cincinnati physicians has raised approximately $10 million in funding, including a recent $250,000 investment from St. Elizabeth Healthcare, the Cincinnati Business Courier reported.
Medtech startup Sense Neuro Diagnostics is developing noninvasive devices to monitor traumatic brain injuries and detect brain hemorrhage or different stroke types. The investment from St. Elizabeth Healthcare will help advance clinical trials for the technology.
“Our technology has the potential to be a total gamechanger for emergency rooms and hospital staff who treat people with traumatic brain injuries and stokes every day,” Geoff Klass, CEO of Sense Neuro Diagnostics, said.
Sense Neuro Diagnostics’ technology can collect 360 data points in 2.5 seconds. More than 20 sites in the United States, Canada and India are conducting trials of the startup’s in-hospital device while five sites are evaluating its military field device.
Read more in the Business Courier.
Featured image at top courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.